EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Germline Disruption of Retinal Pigment Epithelium‐Expressed Zebrafish rlbp1b −/− Results in Selective Dim Light Visual Behavior Deficits and Provides a Screening Platform for Evaluating the Pathogenicity of Human RLBP1 Variants

John D Fehilly iD, Tess McCann iD, Grace Ruddin, Joanna J Kaylor, Hannah Grenville, Rebecca Ward iD, Kieran Wynne, Alicia Gómez Sánchez, Elin Strachan, Gabriel H Travis iD, Ross F Collery, Breandán N Kennedy iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202500600r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von John D Fehilly und 11 weiteren Autor:innen. Beteiligte Einrichtung: UCD School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Retinal Pigment Epithelium, Zebrafish Proteins, Carrier Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NEI NIH HHS, Fighting Blindness, Crystal3 MSCA-RISE consortium.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular retinaldehyde binding protein (CRALBP) plays a crucial role in the visual cycle by chaperoning 11‐ cis ‐retinoids. Mutations in its encoding gene RLBP1 lead to inherited retinal diseases with the common feature of poor night vision. Zebrafish possess two RLBP1 paralogs, rlbp1a and rlbp1b, with distinct retinal expression profiles, providing a bespoke opportunity to dissect cell‐specific functions of CRALBP. Here, we first resolved conflicting reports on paralog expression by interrogating zebrafish single‐cell RNA‐sequencing datasets, which revealed predominant rlbp1a expression in Müller glia and rlbp1b expression in the RPE. Using CRISPR‐generated zebrafish knockouts, we demonstrated that loss of RPE‐expressed rlbp1b selectively impaired optokinetic responses (OKR) with a ~50% reduction in saccade frequency relative to wildtype. This impaired OKR response is only seen when under dim light conditions with no defect seen in standard or bright light rearing conditions. This recapitulates the night blindness presentation in patients with RLBP1 mutations. Retinoid profiling of rlbp1b knockout larvae showed significant decreases in 11‐ cis ‐retinal (62% reduced) and all‐ trans ‐retinal (69% reduced) levels. To explore mechanistic changes following rlbp1b loss, unbiased proteomic profiling was carried out on rlbp1b knockout adult zebrafish eyes. This confirmed the knockout of Cralbpb and revealed significant disruption of proteins involved in vitamin A metabolism, lipid metabolism/storage and ferroptosis. To explore the utility of zebrafish for in vivo pathogenicity assessment of RLBP1 , we established a complementation assay using transgenic zebrafish. Although expression of wildtype EGFP‐tagged human RLBP1 did not rescue the visual deficit, expression of zebrafish Cralbp to the RPE restored dim light vision, whereas zebrafish Cralbp harboring the human pathogenic p.R151Q mutation failed to do so. Together, these findings underscore the predominant role of RPE‐expressed CRALBP in sustaining visual function under low‐light conditions and establish a zebrafish platform for functional evaluation of RLBP1 variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Pigment EpitheliumZebrafish ProteinsCarrier ProteinsAnimalsZebrafishHumansLightAnimals, Genetically Modified

Stichwörter der Autor:innen

RLBP1rlbp1arlbp1bhumanizedknockoutvisionzebrafish

Substanzen

Zebrafish ProteinsCarrier Proteins11-cis-retinal-binding protein

Autor:innen und Institutionen

  • UCD School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
  • UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
  • Department of Ophthalmology, University of California Los Angeles, Los Angeles, California, USA.
  • Systems Biology Ireland, University College Dublin, Dublin, Ireland.
  • Department of Biological Chemistry, University of California Los Angeles, Los Angeles, California, USA.
  • Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

ORCID-Profile: John D Fehilly, Tess McCann, Rebecca Ward, Gabriel H Travis, Breandán N Kennedy

Förderung

  • NEI NIH HHS
  • Fighting Blindness
  • Crystal3 MSCA-RISE consortium
  • NIH HHS
  • National University of Ireland (NUI)
  • Irish Research Council postgraduate scholarship
  • Taighde Eireann Research Ireland
  • Taighde Eireann Research Ireland/Fighting Blindness

Zitieren

APA

Fehilly, J. D., McCann, T., Ruddin, G., Kaylor, J. J., Grenville, H., Ward, R., Wynne, K., Sánchez, A. G., Strachan, E., Travis, G. H., Collery, R. F., & Kennedy, B. N. (2025). Germline Disruption of Retinal Pigment Epithelium‐Expressed Zebrafish rlbp1b −/− Results in Selective Dim Light Visual Behavior Deficits and Provides a Screening Platform for Evaluating the Pathogenicity of Human RLBP1 Variants. The FASEB Journal. https://doi.org/10.1096/fj.202500600r

Vancouver

Fehilly JD, McCann T, Ruddin G, Kaylor JJ, Grenville H, Ward R, et al. Germline Disruption of Retinal Pigment Epithelium‐Expressed Zebrafish rlbp1b −/− Results in Selective Dim Light Visual Behavior Deficits and Provides a Screening Platform for Evaluating the Pathogenicity of Human RLBP1 Variants. The FASEB Journal. 2025. doi:10.1096/fj.202500600r

BibTeX
@article{Fehilly2025,
  author = {Fehilly, John D and McCann, Tess and Ruddin, Grace and Kaylor, Joanna J and Grenville, Hannah and Ward, Rebecca and Wynne, Kieran and Sánchez, Alicia Gómez and Strachan, Elin and Travis, Gabriel H and Collery, Ross F and Kennedy, Breandán N},
  title = {Germline Disruption of Retinal Pigment Epithelium‐Expressed Zebrafish rlbp1b −/− Results in Selective Dim Light Visual Behavior Deficits and Provides a Screening Platform for Evaluating the Pathogenicity of Human RLBP1 Variants},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202500600r}
}
Kostenlos starten →